MICHAEL HERNANDEZ: Open Payments
NPI 1851380885 · CORPUS CHRISTI, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,234 in 18 payments from 7 companies in 2025. Trend: 2023 $1,351 · 2024 $1,631 · 2025 $1,234
Food & beverage: $1,234
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 5 | $332 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $313 |
| Collegium Pharmaceutical, Inc. | 2 | $139 |
| ABBVIE INC. | 2 | $136 |
| Otsuka America Pharmaceutical, Inc. | 1 | $125 |
| E.R. Squibb & Sons, L.L.C. | 1 | $120 |
| Teva Pharmaceuticals USA, Inc. | 1 | $67 |
Products named: CAPLYTA, LYBALVI, Jornay PM, VRAYLAR, REXULTI, COBENFY, ARISTADA, AUSTEDO XR.
Industry payments across TX — which companies pay providers there.
